Occupational Therapists in North Aurora, IL Accepting Medicare

9 Occupational Therapists found. Showing 1 - 9

Alexander James Porter, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr, Suite 102, North Aurora, IL 60542 Phone: 630-907-9165    Fax: 630-907-9195

Angela Therese Spinelli Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr, #102, North Aurora, IL 60542 Phone: 630-907-9165

Samantha Barber, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr Ste 102, North Aurora, IL 60542 Phone: 630-907-9165    Fax: 630-907-9195

Mrs. Megan Anne Tierney, MOTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr Ste 102, North Aurora, IL 60542 Phone: 630-907-9165

Sean Whalen I Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr Ste 102, North Aurora, IL 60542 Phone: 630-907-9165

Lucinda Prisco, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 210 Airport Rd, North Aurora, IL 60542 Phone: 630-896-7778

Wendy Goes, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr Ste 102, North Aurora, IL 60542 Phone: 630-907-9165

Emily Honeyman, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr, North Aurora, IL 60542 Phone: 630-907-9165

Mrs. Katherine Lindstrom Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 66 Miller Dr, Suite 102, North Aurora, IL 60542 Phone: 630-907-9195

News Archive

Scientists develop rapid diagnostic test for detecting meningococcal bacteria

Researchers at Queen's University Belfast and the Belfast Health and Social Care Trust have developed a groundbreaking test for meningitis which could help save lives.A rapid diagnostic test for meningococcal bacteria that can produce results within an hour has been developed by scientists from Queen's Centre for Infection and Immunity and the Trust. The speed of this new test is a vital factor in the treatment of young children with meningococcal meningitis and septicaemia who become very ill over a short period.

FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency

Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.

Pharmasset commences PSI-7977 Phase 2a trial for HCV

Pharmasset, Inc. today announces the initiation of a 28-day Phase 2a study with PSI-7977, a chirally pure isomer form of PSI-7851, a nucleotide analog polymerase inhibitor in development for the treatment of chronic hepatitis C (HCV). The trial will evaluate various doses of PSI-7977 in combination with Pegasys (peginterferon alfa 2a) and Copegus (ribavirin) in patients with HCV genotype 1 who have not been treated previously.

Researchers develop new way to design glycoclusters for targeted drug delivery

A team led by researchers at the RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan has developed a way to engineer glycan complexes-clusters of sugar chains attached to proteins or lipids-in a way that allows the molecules to be transported preferentially to specific organs of the body, depending on the sugar chains contained in the cluster.

GAVI Alliance cited as "game changer" in international development aid

The heads of the US and UK governments' aid programmes have recognised the GAVI Alliance as offering "game changing" lessons in the fight against global poverty.

Read more Medical News

› Verified 4 days ago